Posts

Showing posts with the label brain tumor treatment

Breakthroughs in Brain Tumor Treatment and Mental Wellbeing

  Tumour Related to any part of the body can be a life-altering disease. Especially brain tumour is the most dangerous because it also challenges you emotionally, affecting both physical and emotional well-being. But thankfully, significant advancements in brain tumour treatment have improved patient outcomes and quality of life.   Breakthroughs in Brain Tumor Treatment:       Precision Medicine:  This approach tailors treatment plans to an individual's genetic makeup and tumour characteristics. It allows doctors to provide targeted therapies with fewer side effects, which will provide an improved quality of life with better survival rates.       Immunotherapy:  Immunotherapy revives the immune system to   fight tumours. Although it's still in the early stages , it offers promising   results and renewed hope for patients with limited treatment options.       Minimally Invasive Techniques:  Advancements in surgical techniques reduce in...

Immunotherapy and Brain Tumour Treatment: Empowering the Immune System

  Immunotherapy has emerged as a revolutionary approach in cancer treatment, including brain tumors . By harnessing the power of the immune system, immunotherapy aims to enhance the body's natural defenses against cancer cells.    Let’s learn about immunotherapy and how it is being used in brain tumor treatment .   Understanding Immunotherapy   Immunotherapy is a treatment approach that activates or enhances the body's immune system to recognize and target cancer cells. It utilizes various strategies, such as immune checkpoint inhibitors, cytokines, and adoptive cell transfer, to boost the immune response against tumors .   Immune Checkpoint Inhibitors   Immune checkpoint inhibitors are a class of immunotherapy drugs that block proteins on cancer cells or immune cells, allowing the immune system to recognize and attack the tumor more effectively. In brain tumor treatment, immune checkpoint inhibitors, such as pembrolizumab and nivolumab, are ...